Source: Eur Respir Rev 2009; 18: 51-53
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Humbert M.. Biologics in severe difficult-to-treat asthma: find the right niche!. Eur Respir Rev 2009; 18: 51-53

Member's Comments

No comment yet.

Related content which might interest you: Managing severe asthma: do we need to do more? Source: Annual Congress 2007 - Changing practice with anti-IgE: patient, physician and payor perspectives Year: 2007 Update on severe asthma: what we know and what we need Source: Eur Respir Rev 2009; 18: 58-65 Year: 2009 Neutrophilic asthma: welcome back! Source: Eur Respir J, 54 (5) 1901846; 10.1183/13993003.01846-2019 Year: 2019 Treatment of severe childhood asthma: what’s the evidence? Source: Annual Congress 2005 - Difficult asthma in children Year: 2005 Can we consider the "frequent exacerbator" a reliable COPD phenotype? Source: International Congress 2015 – COPD: chronic disease and comorbidities Year: 2015 Chronic diseases like asthma and COPD: do they truly exist? Source: Eur Respir J 2016; 47: 359-361 Year: 2016 Only severe asthma? Source: International Congress 2019 – PG11 Severe paediatric asthma Year: 2019 A different disease, many diseases or mild asthma gone bad? Challenges of severe asthma Source: Eur Respir J 2003; 22: 397-398 Year: 2003 Paediatric asthma: where to go? Source: Eur Respir Rev 2012 21:173-174 Year: 2012 Paediatric asthma: where to go? Source: Annual Congress 2013 –European Respiratory Review: what's hot in pulmonary medicine Year: 2013 Management of severe and difficult-to-treat asthma Source: Annual Congress 2013 –Severe asthma: moving from phenotyping to endotyping Year: 2013 U-BIOPRED: Towards phenotype handprints of severe asthma Source: Annual Congress 2009 - EU Research Programmes. IMI: 1. U-BIOPRED asthma 2. PROactive COPD Year: 2009 Mild persistent asthma: to treat or not to treat regularly? Source: ERS Live 2007 Year: 2007 Identifying patients at risk for future exacerbations of asthma: Development of a prediction model Source: International Congress 2015 – Non-inflammatory monitoring of airway diseases Year: 2015 Management of severe allergic asthma in the UK: Which monoclonal antibody would you choose? Source: International Congress 2018 – New developments in the treatment of asthma Year: 2018 Adherence and effectiveness of omalizumab treatment in severe allergic asthma patients: Do the patients like injectable treatment? Source: Annual Congress 2013 –Treatment of asthma Year: 2013 Before hospital admission for an exacerbation, asthma patients don’t look alike! Source: International Congress 2016 – Asthma: treatment, disease control, and quality of life Year: 2016 Management of difficult-to-treat severe asthma Source: Eur Respir Mon 2011; 51: 282-296 Year: 2011